Obliquumol, a novel antifungal and a potential scaffold lead compound, isolated from the leaves of Ptaeroxylon obliquum (sneezewood) for treatment of Candida albicans infections

Show simple item record

dc.contributor.author Van Wyk, Candice
dc.contributor.author Botha, Francien Susanna
dc.contributor.author Vleggaar, Robert
dc.contributor.author Eloff, Jacobus Nicolaas
dc.date.accessioned 2019-07-10T07:34:38Z
dc.date.available 2019-07-10T07:34:38Z
dc.date.issued 2018
dc.description.abstract In a random screening of the anti-Candida activity of more than 500 tree species, the acetone leaf extract of Ptaeroxylon obliquum (Thunb.) Radlk. (Sneezewood) had very good antifungal activity against Candida albicans. We isolated the compounds responsible for the antifungal activity by bio-assay guided fractionation. The acetone leaf extract was separated into five fractions by solvent-solvent fractionation. The chloroform fraction was subjected to repeated open column silica gel chromatography. We isolated two antifungal entities and determined the structures by nuclear magnetic resonance spectroscopy. The first entity was a mixture of β-amyrin and lupeol found frequently in other plants that we could not separate. The second entity was a novel compound not isolated before 8,11-Dihydro-5-hydroxy-12-hydroxymethyl-2-methyl-4H-pyrano[2,3-g][1]benzoxepin-4- one 12-O-acetate given the trivial name of obliquumol. Obliquumol had a higher activity against some Candida albicans isolates than amphotericin B, the positive control (MIC of 0.04-0.08 compared to 0.11mg/ml) and lower cellular cytotoxicity against mouse fibroblast cells than amphotericin B. The structure of obliquumol may represent a low toxicity new scaffold molecule for the development of antifungal compounds. en_ZA
dc.description.abstract In ’n voorlopige ondersoek na die aktiwiteit van asetoon blaarekstrakte van meer as 500 boomspesies teen Candida albicans het die ekstrak van Ptaeroxylon obliquum (Thunb.) Radlk. (Nieshout) baie goeie aktiwiteit gehad. Ons het die aktiewe verbindings deur ’n bioaktiwiteit-geleide proses geïsoleer. Die asetoon blaarekstrak is in vyf fraksies verdeel deur oplosmiddel-oplosmiddel fraksionering. Die chloroform fraksie het die hoogste aktiwiteit gehad en is onderwerp aan herhaalde oop-kolom kolomchromatografie. Ons het twee antifungus entiteite geïsoleer en die strukture bepaal deur kernmagnetiese resonansspektroskopie. Die eerste entiteit was ’n mengsel van β-amirien en lupeol, verbindings wat dikwels in plante aangetref word. Die tweede entiteit was ’n molekuul wat nog nie tevore gevind is nie, naamlik 8,11-Dihidro-5-hidroksie-12-hidroksiemetiel-2 metiel-4H-pirano[2,3-g]bensoksiepin-4-oon-12-O-asetaat waaraan ons die algemene naam obliquumol toegeken het. Die verbinding het hoër aktiwiteit as die positiewe kontrole amfoterisien- B teenoor Candida albicans gehad (MIK 0.04-0.08 teenoor 0.11). Dit het ook ’n laer sitotoksisiteit op muis fibroblastselle as amfoterisien-B gehad. Obliquumol se buitengewone struktuur mag as ’n raamwerkmolekuul dien vir die ontwikkeling van nuwe antifungusverbindings. en_ZA
dc.description.department Chemistry en_ZA
dc.description.department Community Dentistry en_ZA
dc.description.department Paraclinical Sciences en_ZA
dc.description.librarian am2019 en_ZA
dc.description.sponsorship The University of Pretoria and the National Research Foundation. en_ZA
dc.description.uri http://www.satnt.ac.za en_ZA
dc.description.uri http://www.satnt.ac.za/index.php/satnt en_ZA
dc.identifier.citation Van Wyk Ca, Botha FS, Vleggaar R and Eloff JN, Obliquumol, a novel antifungal and a potential scaffold lead compound, isolated from the leaves of Ptaeroxylon obliquum (sneezewood) for treatment of Candida albicans infections, Suid-Afrikaanse Tydskrif vir Natuurwetenskap en Tegnologie 37(1). en_ZA
dc.identifier.issn 0254-3486 (print)
dc.identifier.issn 2222-4173 (online)
dc.identifier.uri http://hdl.handle.net/2263/70654
dc.language.iso en en_ZA
dc.publisher AOSIS Open Journals en_ZA
dc.rights © 2018. Authors. Licensee: Die Suid- Afrikaanse Akademie vir Wetenskap en Kuns. This work is licensed under the Creative Commons Attibution License. en_ZA
dc.subject Antifungal en_ZA
dc.subject Isolation en_ZA
dc.subject Structure elucidation en_ZA
dc.subject Minimum inhibitory concentration en_ZA
dc.subject Cytoxicity en_ZA
dc.subject.other Health sciences article SDG-03 en_ZA
dc.subject.other SDG-03: Good health and well-being
dc.title Obliquumol, a novel antifungal and a potential scaffold lead compound, isolated from the leaves of Ptaeroxylon obliquum (sneezewood) for treatment of Candida albicans infections en_ZA
dc.type Article en_ZA


Files in this item

This item appears in the following Collection(s)

Show simple item record